Isturisa is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is Osilodrostat Phosphate.
| Product ID | 55292-321_06e491a0-5048-424a-9fa3-5109679d7908 | 
| NDC | 55292-321 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Isturisa | 
| Generic Name | Osilodrostat | 
| Dosage Form | Tablet, Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2020-03-31 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA212801 | 
| Labeler Name | Recordati Rare Diseases, Inc. | 
| Substance Name | OSILODROSTAT PHOSPHATE | 
| Active Ingredient Strength | 5 mg/1 | 
| Pharm Classes | Cortisol Synthesis Inhibitor [EPC], Cytochrome P450 11B1 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2024-12-31 | 
| Marketing Start Date | 2020-03-31 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA212801 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2020-03-31 | 
| Marketing Category | NDA | 
| Application Number | NDA212801 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2020-03-31 | 
| Ingredient | Strength | 
|---|---|
| OSILODROSTAT PHOSPHATE | 5 mg/1 | 
| SPL SET ID: | f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 55292-320 | Isturisa | Osilodrostat | 
| 55292-321 | Isturisa | Osilodrostat | 
| 55292-322 | Isturisa | Osilodrostat | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  ISTURISA  79187535  5061675 Live/Registered | NOVARTIS AG 2016-03-30 |